Kewaunee Scientific Corporation
KEQU
$34.88
$0.320.93%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 220.03M | 199.64M | 202.31M | 203.76M | 201.04M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 220.03M | 199.64M | 202.31M | 203.76M | 201.04M |
| Cost of Revenue | 160.57M | 146.53M | 149.68M | 151.70M | 153.27M |
| Gross Profit | 59.46M | 53.11M | 52.63M | 52.05M | 47.77M |
| SG&A Expenses | 48.70M | 40.83M | 39.71M | 37.95M | 32.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 209.26M | 187.36M | 189.40M | 189.65M | 185.76M |
| Operating Income | 10.76M | 12.28M | 12.91M | 14.10M | 15.28M |
| Income Before Tax | 8.98M | 11.22M | 12.14M | 13.12M | 14.09M |
| Income Tax Expenses | -8.83M | -7.74M | -6.64M | -5.94M | 5.12M |
| Earnings from Continuing Operations | 17.82 | 18.97 | 18.78 | 19.06 | 8.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -234.00K | -217.00K | -308.00K | -304.00K | -240.00K |
| Net Income | 17.58M | 18.75M | 18.47M | 18.75M | 8.73M |
| EBIT | 10.76M | 12.28M | 12.91M | 14.10M | 15.28M |
| EBITDA | 14.77M | 15.54M | 16.13M | 17.23M | 18.31M |
| EPS Basic | 6.15 | 6.55 | 6.44 | 6.54 | 3.03 |
| Normalized Basic EPS | 1.88 | 2.37 | 2.52 | 2.74 | 2.98 |
| EPS Diluted | 5.91 | 6.31 | 6.23 | 6.35 | 2.97 |
| Normalized Diluted EPS | 1.81 | 2.29 | 2.47 | 2.69 | 2.93 |
| Average Basic Shares Outstanding | 11.45M | 11.47M | 11.50M | 11.51M | 11.49M |
| Average Diluted Shares Outstanding | 11.91M | 11.88M | 11.84M | 11.75M | 11.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |